Complementary and alternative medicine use among patients with thoracic malignancies
Rashmi S Bismark1, Hongbin Chen, Grace K Dy
1Roswell Park Cancer Institute, Buffalo, NY, USA, rsbismar@buffalo.edu.
Summary
Fear about the future is linked to complementary and alternative medicine (CAM) use in thoracic cancer patients. Patients may use CAM to cope with emotional distress during cancer treatment.
Area of Science:
- Oncology
- Integrative Medicine
Background:
- Complementary and alternative medicine (CAM) use is rising among cancer patients.
- Characterizing CAM use in thoracic malignancies is crucial for understanding patient care.
Purpose of the Study:
- To determine the prevalence of CAM use in patients with thoracic malignancies.
- To identify predictors of CAM use in this population.
Main Methods:
- A cross-sectional study was conducted at a comprehensive cancer center.
- 108 adult patients with thoracic malignancies completed a survey on CAM use.
- Logistic regression analyzed predictors of CAM use.
Main Results:
- 42% of patients reported using at least one form of CAM.
- CAM use was not associated with demographics, diagnosis, or quality of life.
- Fear about the future significantly predicted CAM use (OR=4.18).
Conclusions:
- CAM prevalence in thoracic cancer patients mirrors the general US population.
- Fear and emotional distress are associated with CAM use.
- CAM may serve as a coping mechanism for cancer-related emotional distress.
Related Concept Videos
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
